'Your papers, please' must never be heard in America
Independent voices from the TWT Communities
Confused about the federal budget struggle? So are doctors, hospital administrators and other medical professionals who serve the 100 million Americans covered by Medicare and Medicaid.
The Obama administration has strengthened the prescription drug coverage that will be available to the millions of people who will get insurance through the nation's new health care overhaul starting late next year.
Millions of seniors enrolled in some of the most popular Medicare prescription drug plans face double-digit premium hikes next year if they don't shop for a better deal, says a private firm that analyzes the highly competitive market.
Seniors enrolled in seven of the 10 most popular Medicare prescription drug plans will be hit with double-digit premium hikes next year if they don't shop for a better deal, says a private firm that analyzes the highly competitive market.
Seniors enrolled in seven of the 10 most popular Medicare prescription drug plans will be hit with double-digit premium increases next year if they don't shop for a better deal, says a private firm that analyzes the highly competitive market.
Chemotherapy is now available in a pill, but if you have Medicare, you may not be able to afford it.
Millions of seniors in popular private insurance plans offered through Medicare will be getting a reprieve from some of the most controversial cuts in President Barack Obama's health care law.
Millions of seniors in popular private insurance plans offered through Medicare will be getting a reprieve from some of the most controversial cuts in President Obama's health care law.
Millions of seniors face double-digit hikes in their Medicare prescription premiums next year unless they actively search out cheaper coverage, a new analysis of government data finds.
"There is no political consensus to do anything significant," said Dan Mendelson, president of Avalere Health, a market analysis firm. "There is a collective walking away from things that matter. All the stuff on the lists of options becomes impossible, because there is no give-and-take."
"It's going to dramatically increase access to pharmaceuticals in the exchanges," Mr. Mendelson said. "It's a big deal. This makes the exchange offerings more consistent with what employers offer."
